---
category: news
title: "Progenics Pharmaceuticals Completes Enrollment in Pivotal Phase 3 CONDOR Study of PyL for the Detection of Prostate Cancer"
abstract: "About PROGENICSProgenics is an oncology company focused on the development and commercialization of innovative targeted medicines and artificial intelligence to find ... who require systemic anticancer therapy; and RELISTORÂ® (methylnaltrexone bromide ..."
publishedDateTime: 2019-08-05T16:29:00Z
sourceUrl: https://www.bakersfield.com/ap/news/progenics-pharmaceuticals-completes-enrollment-in-pivotal-phase-condor-study-of/article_40f855b0-48e4-5990-be86-24fffebe0d03.html
type: article
quality: 11
score: 11
published: false

provider:
  name: The Bakersfield Californian
  id: bakersfield.com

topics:
  - AI
  - AI in Healthcare

images:
  - url: https://frontpages.bakersfieldcdn.com/TBC/frontpage-large.jpg
    width: 500
    height: 1100
    title: "Progenics Pharmaceuticals Completes Enrollment in Pivotal Phase 3 CONDOR Study of PyL for the Detection of Prostate Cancer"
---
